SKIN The Journal of Cutaneous Medicine

Appropriate Use Criteria for the Integration of Diagnostic and Prognostic Gene Expression Profile Assays into the Management of Cutaneous Malignant Melanoma: An Expert Panel Consensus-Based Modified Delphi Process Assessment

Brian Berman, Roger Ceilley, Clay Cockerell, Laura Ferris, Whitney A High, Mark Lebwohl, Mark S Nestor, Theodore Rosen, Graham H Litchman, Giselle Prado, Ryan M Svoboda, Darrell S Rigel

Page 291-306

Full Article PDF

A Systematic Review and Meta-Analysis of Gene Expression Profiling for Primary Cutaneous Melanoma Prognosis

Graham H Litchman, Giselle Prado, Rebeca W Teplitz, Darrell Rigel

Page 221-237

PDF

Establishing an evidence-based decision point for clinical use of the 31-gene expression profile test in cutaneous melanoma

Etan Marks, Hillary G. Caruso, Sarah J Kurley, Sidra Ibad, Kristen M Plasseraud, Federico A Monzon, Clay J Cockerell

Page 239-249

Full Article PDF

31-Gene Expression Profile Assessing Metastatic Risk in Melanoma Patients: Issues Impacting Patient Selection

Ryan M Svoboda, Alex M Glazer, Darrell S Rigel

Page s105

Poster PDF

Histopathologic discordance in melanoma can have substantial impacts on patient care

Alex Glazer, Clay Cockerell

Page 85-89

Full Article PDF

Attitudes of Patients with Cutaneous Melanoma Towards Prognostic Testing Using Gene Expression Profiling

Lorrie-Beth Miley, Kelli Ahmed, Jennifer Siegel, Sonia Morgan-Linnell

Page s23

Poster PDF

Clinical Impact of a 31-Gene Expression Profile Test on Physician Recommendations for Management of Melanoma Patients in a Prospectively Tested Cohort

Martin Fleming, Clare Johnson, Kyle Covington, Joseph Gadzia, Larry Dillon, Federico A Monzon

Page S42

Poster PDF

A Retrospective Case Series to Evaluate the Clinical Utility of a 31-Gene Expression Profile Test in Cutaneous Melanoma Patients

Robert W Cook, Federico A Monzon, David Hyams

Page S44

Poster PDF

Non-Invasive Genomic Profiling in Pediatric Patients

Allyson Perry, Danielle Ruppenthal, Kellie Hill

Page s198

Poster PDF

Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease

David Hyams, Jung S. Byun, Brian Martin, Christine N. Bailey, Timothy Stumpf, Valentina I. Petkov

Page s223

Poster PDF

Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced Into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma

Daniel Siegel , Christopher Murphy , Kent Wangsness, Allyson Perry , Ian Smith

Page 109-121

PDF

Search

Search Results